Table 2.
COVID-19 symptoms experienced by respondents
| Symptoms | COVID-19 symptoms N=616 |
Symptoms ≥3 months after infection n=334 |
| Extreme fatigue, n (%) | 543 (88.1) | 266 (79.6) |
| Headaches, n (%) | 490 (79.5) | 214 (64.1) |
| Cough/noisy breathing, n (%) | 452 (73.4) | 174 (52.1) |
| General muscle weakness, n (%) | 444 (72.1) | 191 (57.2) |
| Muscle or joint pain, n (%) | 435 (70.6) | 196 (58.7) |
| Shortness of breath with activity, n (%) | 402 (65.3) | 218 (65.3) |
| Issues with concentration, thinking and memory, n (%) | 395 (64.1) | 256 (76.6) |
| Issues with pain or discomfort, n (%) | 384 (62.3) | 174 (52.1) |
| Difficulty sleeping, n (%) | 320 (51.9) | 203 (60.8) |
| Anxiety, n (%) | 317 (51.5) | 205 (61.4) |
| Shortness of breath at rest, n (%) | 301 (48.9) | 156 (46.7) |
| Dizziness, faint, loss of consciousness, n (%) | 256 (41.6) | 164 (49.1) |
| Chest pain at activity, n (%) | 247 (40.1) | 137 (41.0) |
| Depression, n (%) | 247 (40.1) | 176 (52.7) |
| Chest pain at rest, n (%) | 224 (36.4) | 107 (32.0) |
| Difficulty eating, drinking and swallowing, n (%) | 215 (34.9) | 73 (21.8) |
| Difficulty walking, n (%) | 180 (29.2) | 103 (30.8) |
| Difficulty controlling movement of the body, n (%) | 130 (21.1) | 75 (22.5) |
| Other, n (%) | 190 (30.8) | 71 (21.3) |
| Change in taste and smell | 49 (8.0) | 24 (7.2) |
| Sore throat | 48 (7.8) | 8 (2.4) |
| Congestion | 31 (5.0) | <5 (<1.5) |
| Gastrointestinal symptoms | 30 (4.9) | 10 (3.0) |
| Runny nose | 27 (4.4) | <5 (<1.5) |
| Fever | 27 (4.4) | 0 |
| Rapid or irregular heart rate | 17 (2.8) | 16 (4.8) |
| Chills/night sweats | 13 (2.1) | <5 (<1.5) |
| Tinnitus and earache | 11 (1.8) | 82 (2.4) |
| Inflammation and numbness | 10 (1.6) | 17 (5.1) |
| Malaise | 9 (1.5) | 0 |
| Sore eyes and changes in vision | 8 (1.3) | 6 (1.8) |
| Rash | 7 (1.1) | 8 (2.4) |
Questions were not mandatory; not all respondents responded to each question.
Bold indicates most commonly reported symptoms.